Search

everythinglearnresearchcommunity

for

Search:↓

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Breathing in fine particles or Asian dust short-term doesn't affect schoolchildren's skin symptoms.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

SLE in Iraqi patients often involves hair loss and photosensitivity, with common treatments being corticosteroids and immunosuppressants.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Microneedles are promising for disease monitoring and drug delivery due to their minimal invasiveness and versatility.

lncRNAs are important for understanding and treating skin diseases.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.